ADVANCES IN THE DIAGNOSIS PATHOGENESIS AND TREATMENT OF CIDP PDF

  • June 24, 2019

Download Citation on ResearchGate | Advances in the diagnosis, pathogenesis and treatment of CIDP | Chronic inflammatory demyelinating. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens. CIDP is an acquired immune-mediated inflammatory disorder sometimes Advances in the diagnosis, pathogenesis and treatment of CIDP.

Author: Kagashura Fegul
Country: Russian Federation
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 25 August 2012
Pages: 409
PDF File Size: 20.27 Mb
ePub File Size: 7.40 Mb
ISBN: 657-3-83720-580-8
Downloads: 59973
Price: Free* [*Free Regsitration Required]
Uploader: Nihn

Advances in our understanding of the underlying immunopathology in CIDP have identified new targets for future therapeutic efforts, including T cells, B cells, and transmigration and transduction molecules. Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Search for additional papers on this topic. Antonis FanouriakisDimitrios T. Kenneth Craig Gorson Therapeutic advances in neurological disorders By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy PolicyTerms of Serviceand Dataset License.

MRI assessment including apparent diffusion coefficient. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Current diagnosis of CIDP: Dalakas The Lancet Neurology Maintenance therapy with IVIg can induce sustained remission, increase quality of life and prevent further axonal loss, but caution is needed to avoid overtreatment.

  ADMINISTRACION DE PERSONAL Y RECURSOS HUMANOS WERTHER Y DAVIS PDF

Skip annd search form Skip to main content. Brannagan Journal of the peripheral nervous system: This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens, and discusses current treatments, ongoing challenges and future therapeutic directions. Topics Discussed in This Paper.

John David PollardPatricia J. Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy Marinos C. This paper has been referenced on Twitter 1 time over the past 90 days.

Advances in the diagnosis, pathogenesis and treatment of CIDP

Citations Publications citing this paper. Chronic inflammatory demyelinating polyneuropathy CIDP is the most common chronic autoimmune neuropathy. Showing of references.

An open label clinical trial of complement inhibition in multifocal motor neuropathy. From This Paper Figures, tables, and topics from this paper.

Untitled Document

Showing of thr extracted citations. Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice.

  DEGLOBALIZATION WALDEN BELLO PDF

Evidence from Human and Animal Studies: References Publications referenced by this paper. An update on the management of chronic inflammatory demyelinating polyneuropathy. New biomarkers and scoring systems represent emerging tools with the potential to predict therapeutic responses and identify patients with active disease for enrollment into clinical trials.

Despite clinical challenges in diagnosis-owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination-consensus criteria seem to have been reached for research or clinical practice.

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Immunoglobulins, Intravenous Demyelinating peripheral neuropathy Polyneuropathy.

Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Commonly used immunosuppressive drugs offer minimal benefit, necessitating the development of new therapies for treatment-refractory patients. Bertsias Current opinion in rheumatology Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies. BoumpasGeorge K.